Structure Therapeutics American Stock Probability of Future Stock Price Finishing Over 53.07
| GPCR Stock | 53.07 2.56 4.60% |
Structure |
Structure Therapeutics Target Price Odds to finish over 53.07
The tendency of Structure Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 53.07 | 90 days | 53.07 | near 1 |
Based on a normal probability distribution, the odds of Structure Therapeutics to move above the current price in 90 days from now is near 1 (This Structure Therapeutics American probability density function shows the probability of Structure Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Structure Therapeutics American has a beta of -0.0804. This usually indicates as returns on the benchmark increase, returns on holding Structure Therapeutics are expected to decrease at a much lower rate. During a bear market, however, Structure Therapeutics American is likely to outperform the market. Additionally Structure Therapeutics American has an alpha of 0.652, implying that it can generate a 0.65 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta). Structure Therapeutics Price Density |
| Price |
Predictive Modules for Structure Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Structure Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Structure Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Structure Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Structure Therapeutics is not an exception. The market had few large corrections towards the Structure Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Structure Therapeutics American, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Structure Therapeutics within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | 0.65 | |
β | Beta against NYSE Composite | -0.08 | |
σ | Overall volatility | 5.04 | |
Ir | Information ratio | 0.08 |
Structure Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Structure Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Structure Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Structure Therapeutics is way too risky over 90 days horizon | |
| Structure Therapeutics appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (89.54 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Structure Therapeutics generates negative cash flow from operations | |
| Structure Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Over 81.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Structure Therapeutics Announces Pricing of Upsized 476 Million Public Offering |
Structure Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Structure Stock often depends not only on the future outlook of the current and potential Structure Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Structure Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 36.7 M | |
| Cash And Short Term Investments | 467.3 M |
Structure Therapeutics Technical Analysis
Structure Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Structure Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Structure Therapeutics American. In general, you should focus on analyzing Structure Stock price patterns and their correlations with different microeconomic environments and drivers.
Structure Therapeutics Predictive Forecast Models
Structure Therapeutics' time-series forecasting models is one of many Structure Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Structure Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Structure Therapeutics
Checking the ongoing alerts about Structure Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Structure Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Structure Therapeutics is way too risky over 90 days horizon | |
| Structure Therapeutics appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (89.54 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Structure Therapeutics generates negative cash flow from operations | |
| Structure Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Over 81.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Structure Therapeutics Announces Pricing of Upsized 476 Million Public Offering |
Additional Tools for Structure Stock Analysis
When running Structure Therapeutics' price analysis, check to measure Structure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Structure Therapeutics is operating at the current time. Most of Structure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Structure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Structure Therapeutics' price. Additionally, you may evaluate how the addition of Structure Therapeutics to your portfolios can decrease your overall portfolio volatility.